Media Library

Novartis executives and dignitaries cut ribbon on Novartis RLT manufacturing facility in Carlsbad, California, USA (November 10, 2025).

Novartis executives and dignitaries at the ribbon cutting ceremony for the RLT manufacturing facility in Carlsbad, California, USA (November 10, 2025).

Exterior view of our state-of-the-art radioligand therapy (RLT) manufacturing facility in Carlsbad, California, United States.

Novartis executives and dignitaries at the groundbreaking ceremony of the US Flagship Manufacturing Hub in Durham, North Carolina, USA (December 11, 2025).

Vas Narasimhan, Novartis CEO, with Josh Stein, Governor of North Carolina, at the groundbreaking ceremony of the US Flagship Manufacturing Hub in Durham, North Carolina, USA (December 11, 2025).

Vas Narasimhan, Novartis CEO (left) and Victor Bultó, President Novartis US (right), with Dr. Marty Makary, FDA Commissioner, at the groundbreaking ceremony of the US Flagship Manufacturing Hub in Durham, North Carolina, USA (December 11, 2025).

Chief Audit Officer since July 1, 2025

Board member since 2025

Chair since 2025

The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards.

The Annual Report 2024, filed with the SIX Swiss Exchange in Switzerland, provides a comprehensive overview of Novartis, including our company structure, corporate governance, operating and financial results, and compensation practices.

The Novartis in Society Integrated Report covers our business, strategy and performance. It highlights progress against our ESG targets and describes how we create sustainable value for diverse stakeholders. It follows requirements of the Swiss Code of Obligations and various voluntary reporting frameworks and standards.